2021 ESC Pocket Guidelines on cardiovascular disease prevention in clinical practice
Szabados Eszter, Sándor Barbara, Pálfi Anita
Pécsi Tudományegyetem, Klinikai Központ, I. sz. Belgyógyászati Klinika, Kardiológiai Prevenciós és
Rehabilitációs Tanszék, Pécs
Dr. Szabados Eszter, Pécsi Tudományegyetem, Klinikai Központ, I. sz. Belgyógyászati Klinika
Kardiológiai Prevenciós és Rehabilitációs Tanszék, 7624 Pécs, Rákóczi út 2. E-mail: email@example.com
The 2021 European Society of Cardiology guideline on cardiovascular disease prevention aimed to help health professionals in their clinical judgment, as well as in the implementation of preventive, diagnostic or therapeutic medical strategies, when treating patients with or without established atherosclerotic cardiovascular disease, or those with high risk for future cardiovascular events. The major risk factors for atherosclerotic cardiovascular disease are high cholesterol, hypertension, cigarette smoking, diabetes mellitus and obesity. These risk factors should be treated in a stepwise approach to reach the ultimate treatment goals. The new SCORE2 and SCORE2-OP risk calculators, calibrated for 4 geographic regions, help age-specific 10-year fatal and non-fatal CVD risk estimation for apparently healthy people and support the treatment decisions for risk factor management. The guideline introduces “lifetime risk” into the decision-making process, as well as lifelong treatment benefits, which can be applied not only to apparently healthy individuals but also to patients with established ASCVD or diabetes. The guideline encourages health professionals to apply these recommendations widely, but also emphasizes that it should in no way override the individual responsibility of healthcare professionals to make appropriate and accurate decisions based on the health status of individual patients.